Navigation Links
Medco Issues $1.5 Billion of Senior Notes
Date:3/13/2008

FRANKLIN LAKES, N.J., March 13 /PRNewswire-FirstCall/ -- Medco Health Solutions, Inc. (NYSE: MHS) announced today that it has agreed to sell $300 million aggregate principal amount of 6-1/8 percent senior notes due March 15, 2013 and $1.2 billion aggregate principal amount of 7-1/8 percent senior notes due March 15, 2018 in an underwritten public offering. Citi, J.P. Morgan Securities Inc., Banc of America Securities LLC and Barclays Capital Inc. are acting as representatives of the several underwriters.

Medco intends to use the net proceeds from the offering to repay borrowings under its senior unsecured revolving credit facility used to fund the acquisition of PolyMedica Corporation in October 2007. The offering is expected to close on March 18, 2008. The prospectus supplement and accompanying prospectus related to the offering of the notes may be obtained by contacting:

Citigroup Global Markets Inc.

Brooklyn Army Terminal,

140 58th Street, 8th Floor,

Brooklyn, NY 11220

Tel: (877) 858 5407

J.P. Morgan Securities Inc.

270 Park Avenue, 8th Floor,

New York, New York, 10017

Tel: (212) 834-4533

Banc of America Securities LLC

Capital Markets Operations

100 West 33rd Street, 3rd Floor

New York, NY 10001

Tel: (800) 294-1322

Barclays Capital Inc.

200 Park Avenue

New York, NY 10166

Attention: Fixed Income Syndicate

Tel: (888) 227-2275

Electronic copies of the prospectus supplement and accompanying prospectus are also available on the Securities and Exchange Commission Web site at http://www.sec.gov.

This press release does not constitute an offer to sell
'/>"/>

SOURCE Medco Health Solutions, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Addressing the Pharmacist Shortage: Medco Labor Coalition(TM) Launches National Scholarship Program to Support the Development of the Next Generation of Pharmacists
2. Medco Chooses AllPoints at Anson in Whitestown, Indiana as Site for the Worlds Largest, Most-Advanced Automated Pharmacy
3. Medco to Webcast Annual Analyst Day Conference
4. Medco Announces Agreement to Acquire Diabetes Care Leader PolyMedica in Transaction Valued at $1.5 Billion
5. SectorWatch.biz Issues MarketStats on CVBT, BSX, MDT, CXM and DNA
6. Solstice Neurosciences, Inc. Issues Corporate Response to FDA Early Communication
7. Insmed CEO Issues Statement on White House FY09 Budget and FDA Statements on Follow-On Biologics
8. Baxter Issues Urgent Nationwide Voluntary Recall of Heparin 1,000 Units/mL 10 and 30mL Multi-Dose Vials
9. FDA Issues Approvable Letter for LUVOX(R) CR (Fluvoxamine Maleate) Extended-Release Capsules for the Treatment of Social Anxiety Disorder (SAD) and Obsessive Compulsive Disorder (OCD)
10. Maryland Stem Cell Commission Issues Nationwide Request for Applications for New Post-Doctoral Fellowship Grants
11. CCPM Issues Statement on FDAs GIVE Initiative

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/9/2009)...O, Nov. 9 NexBio, Inc. announced t...rican College of Allergy, Asthma, and Immunology i...DAS181 (Fludase®), a Sialidase, Decreases Air...fects in Animal Models of Asthma". ,, DAS181 (F...um host-targeting drug candidate being studied in ...
(Date:11/8/2009)...2009 As global temperatures and energy costs cont...key to a sustainable future. An attractive repla... published online in Genome Research ( www.genom...tures of bioethanol-producing microorganisms, unco...loping new technologies needed to implement produc...
(Date:11/6/2009)...Ontario, Nov. 6 Helix Bi...F) today announced that John Docherty, president a...an Curhan Ford,s 6th annual Investor Summit on Nov...New York City. Mr. Docherty will provide an overv...rograms L-DOS47 and Topical Interferon Alpha-2b. ...
(Date:11/6/2009)... Nov. 6 /PRNewswire-FirstCall/ - Oncolytics Biotec... "Company") today announced updated results from a...ents with sarcomas metastatic to the lung in a pos...sue Oncology Society Meeting held in Miami Beach, ...entation, entitled "A Phase II Study of Intravenou...
Breaking Biology Technology:NexBio(R) Presents Data Showing Anti-Asthma Activity of DAS181 (Fludase(R)*) at ACAAI 2009 2NexBio(R) Presents Data Showing Anti-Asthma Activity of DAS181 (Fludase(R)*) at ACAAI 2009 3Genomes of biofuel yeasts reveal clues that could boost fuel ethanol production worldwide 2Helix BioPharma to Present at Merriman Curhan Ford's Investor Summit 2009 on November 10th 2Helix BioPharma to Present at Merriman Curhan Ford's Investor Summit 2009 on November 10th 3Oncolytics Biotech(R) Inc. Collaborators Present Positive Phase II Sarcoma Trial Results at CTOS Annual Meeting 2Oncolytics Biotech(R) Inc. Collaborators Present Positive Phase II Sarcoma Trial Results at CTOS Annual Meeting 3
... transplantation studies , hNT BlueNeurons Expr...hael McGrogan * Guadalupe Gonzalez * Waldemar Lern...a , , Stratagene,s hNT BlueNeurons express bet...rom a clone of the NT2 teratocarcinoma stably tran...use they are easily distinguished from,surroundi...
...lt heterologous proteins , Carsten-Peter Car...as created variants of the Epicurian Coli ,BL2...series** of strains, which contain extra copies of...is modification allows for a high-level,expressi...nventional E. coli,hosts due to the codon bias o...
...as little as 50 ng of RNA , Barry R. Neiditc...,John C. Bauer Mike Kobrin Quinn Lu Dianne Ec...ng ,Human Genome Sciences, Rockville, Maryland ,...uction Kit, which,introduces a new method to gen...,vector. Use this kit with either enriched poly(A...
Other Biology Technology:hNT BlueNeurons Express b-Galactosidase at High ,Levels 2hNT BlueNeurons Express b-Galactosidase at High ,Levels 3hNT BlueNeurons Express b-Galactosidase at High ,Levels 4hNT BlueNeurons Express b-Galactosidase at High ,Levels 5Codon Bias-Adjusted BL21 Derivatives for Protein Expression 2Codon Bias-Adjusted BL21 Derivatives for Protein Expression 3Codon Bias-Adjusted BL21 Derivatives for Protein Expression 4Codon Bias-Adjusted BL21 Derivatives for Protein Expression 5Codon Bias-Adjusted BL21 Derivatives for Protein Expression 6Codon Bias-Adjusted BL21 Derivatives for Protein Expression 7Constructing Directional cDNA Libraries from Limited Amounts of RNA 2Constructing Directional cDNA Libraries from Limited Amounts of RNA 3Constructing Directional cDNA Libraries from Limited Amounts of RNA 4Constructing Directional cDNA Libraries from Limited Amounts of RNA 5Constructing Directional cDNA Libraries from Limited Amounts of RNA 6Constructing Directional cDNA Libraries from Limited Amounts of RNA 7
(Date:11/9/2009)...government and industry researchers has completed ...enome. The project is an important first step in a...ce crop and addressing some of the many limitation...Cassava is a root crop that serves as the primary ...day. Although it has many properties that make it ...
(Date:11/9/2009)...., Nov. 9 Genencor, a division of ...Award" from the American Institute of Chemical Eng... enzymes for cellulosic ethanol. Yesterday, Robert...nted the award to Landon Steele, who is Marketing ...oduct Manager, and Aaron Kelley, who is Senior Eng...
(Date:11/9/2009)... responsible for the rapid, mysterious death of ph...ound by collaborating scientists at Rutgers Univer...(WHOI). This same chemical may hold unexpected pr...a previously unknown lipid, or fatty compound, in ...ania huxleyi , a phytoplankton that plays a major ...
Breaking Biology News(10 mins):Researchers complete draft genome sequence for cassava 2Researchers complete draft genome sequence for cassava 3Researchers complete draft genome sequence for cassava 4Genencor Wins The American Institute of Chemical Engineers (AIChE) Sustainable Energy Award For Accellerase(R) Cellulosic Ethanol Enzymes 2Newly discovered fat molecule: An undersea killer with an upside 2Newly discovered fat molecule: An undersea killer with an upside 3Newly discovered fat molecule: An undersea killer with an upside 4Tobacco Control Bill Heads to White House as Health Groups Cheer 48777 1Tobacco Control Bill Heads to White House as Health Groups Cheer 48777 2Tobacco Control Bill Heads to White House as Health Groups Cheer 48777 3No Time for Complacency in Pandemic Planning 3A Aon 48774 1No Time for Complacency in Pandemic Planning 3A Aon 48774 2No Time for Complacency in Pandemic Planning 3A Aon 48774 3New Studies Show Nursing Workforce Critical to Success of Health Reform 48770 1New Studies Show Nursing Workforce Critical to Success of Health Reform 48770 2New Studies Show Nursing Workforce Critical to Success of Health Reform 48770 3New Studies Show Nursing Workforce Critical to Success of Health Reform 48770 4New Studies Show Nursing Workforce Critical to Success of Health Reform 48770 5New Studies Show Nursing Workforce Critical to Success of Health Reform 48770 6
...IDENCE, R.I. [Brown University] Brown University ...hat could someday help fight the aging process. , ... and others adds another piece to the puzzle that ..., cell biology and biochemistry, first discovered ...e Indy ("I,m Not Dead Yet") gene that can extend t...
...ST LAFAYETTE, Ind. - Researchers have created a pr...tentially many other biological molecules by using...ubes anchored to gold-coated "nanocubes." , The d...h tetherball is a sensor and is anchored to electr... tether and ultrathin wire to conduct electrical s...
... LANSING, Mich. A patented Michigan State Univers...version into ethanol means extra nutrients don,t h...ls from cellulose. , The AFEX (ammonia fiber expa...le, University Distinguished Professor of chemical...o make the breakdown of cellulose and hemicellulos...
Other Biology News:Scientists unlock possible aging secret in genetically altered fruit fly 2Nano-tetherball biosensor precisely detects glucose 2Nano-tetherball biosensor precisely detects glucose 3Nano-tetherball biosensor precisely detects glucose 4Process can cut the cost of making cellulosic biofuels 2
Equine Immunoglobulin G from Equitech-Bio
LIGHT DIAGNOSTICS™ Calicivirus Genotype 1&2 OligoDetect® from CHEMICON
Secure-Seal™ hybridization chamber gasket, eight chambers, 9 mm diameter, 0.8 mm deep *set of 20* from Molecular Probes (Invitrogen)
Rabbit Anti-SRC-RSV Polyclonal Antibody, Unconjugated from AbD Serotec
Biology Products: